DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Immunohistochemistry—A Digital Quantitative Pilot Study
Annika Spitzer, Heike Aupperle-Lellbach, Martin Spitzer, Silvia Weidle, Leonore Aeschlimann, Joshua Schwinn, Robert Klopfleisch, Simone de Brot, Erik Teske · 2025
Read DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Immunohistochemistry—A Digital Quantitative Pilot Study by Annika Spitzer, Heike Aupperle-Lellbach, Martin Spitzer, Silvia Weidle, Leonore Aeschlimann, Joshua Schwinn, Robert Klopfleisch, Simone de Brot, Erik Teske (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12737483.txt.
Description
Annika Spitzer and colleagues published a 2025 pilot study of two proteins in dog cancers. The proteins help organize chromatin in cell nuclei. Human cancers show altered levels with prognostic meaning. Veterinary evidence was almost absent. Samples covered prostate and bladder tumors and healthy tissues.
Digital staining measured nuclear protein levels precisely. One protein consistently showed higher levels than the other. Their levels rose and fell together across samples. Prostate tumors exceeded healthy prostate tissue for one protein. Bladder tumors lost expression as grade worsened. Patterns differ by organ, mirroring human complexity. Bigger studies can test prognostic value in dogs.
Catalog record
| CREATOR | Annika Spitzer, Heike Aupperle-Lellbach, Martin Spitzer, Silvia Weidle, Leonore Aeschlimann, Joshua Schwinn, Robert Klopfleisch, Simone de Brot, Erik Teske |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |